Denmark shows first clear evidence of the success of treatment as prevention in gay men in a high income country

Very high diagnosis, treatment and viral suppression rates needed, say researchers

A study by the University of California, Los Angeles, and Copenhagen University Hospital provides the first unambiguous evidence of a link between high rates of viral suppression in gay men and falling HIV incidence (the proportion of men who catch HIV each year).

The researchers say that HIV incidence among gay men, at a rate of 0.14% a year or one in 700 gay men infected annually, is now so low that it approaches the one per 1000 annual incidence rate that the World Health Organization has set as the threshold for eventually eliminating the HIV epidemic.

They estimate that the percentage of gay men and other men who have sex with men (MSM) in Denmark who have HIV and an undetectable viral load on treatment is now 72.1% – very close to the 72.9% that UNAIDS’ 90/90/90 target sets for ending the HIV epidemic.

Denmark’s HIV epidemic has long been concentrated in MSM and in particular has had very low HIV prevalence in people who inject drugs due to harm reduction programmes being available for decades. Reducing HIV in MSM would therefore reduce it in the whole country.

The researchers find that the reduction in HIV incidence was not driven by changes in the CD4 count threshold for starting treatment, as it started falling before guidelines were changed. Instead, increased rates of testing drew more people into medical care directly and so they were diagnosed earlier, at higher CD4 cell counts.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below